Fennec Pharmaceuticals Stock (NASDAQ: FENC)

Fennec Pharmaceuticals (NASDAQ:FENC) Stock, Quote.Headers.trade-ideas

Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

NYSE

Earnings

Equities

Market Summary

News

Commodities

Economics

Federal Reserve

Markets

Movers

General

$BTC

ALGS

ASAN

BNTX

SPDR Dow Jones Industrial Average ETF Trust

FENC

HSAI

LFMD

NPWR

ORCL

PLTR

RAND

RDFN

SUPV

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

Select Sector SPDR-Consumer Discretionary

Stocks extended last week&#39;s losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.

Nasdaq, S&amp;P 500 Hit 6-Month Lows As Recession Fears Grow: What&#39;s Driving Markets Monday?

Wall Street

CENX

DOGZ

MAZE

MBOT

MGOL

MYNA

ORIS

PLRX

PNBK

PSIG

REPL

SATL

SLDB

SMTC

STBX

YOSH

Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

alibaba_logo

Intraday Update

AGYS

AKYA

AUGX

BABA

BETR

BIOL

BYND

CLOV

CTNT

DCTH

DWSN

EAST

FFIE

FOSL

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HROW

INVO

JAMF

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MBIN

NOTV

NOVA

ONON

PLUG

PSFE

RENT

SCPX

SHIM

SMRT

Sony Group Corporation American Depositary Shares

SONY

SPCE

SPWR

STNE

SYRA

TLRY

UXIN

VUZI

WOOF

WULF

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Fennec Pharmaceuticals Inc. - Common Stock

Fennec Pharmaceuticals Inc

Management

Press Releases

Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of Growth

Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

Financing

Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management

Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

Health Care

Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Comments

Fennec Pharmaceuticals

Fennec Pharmaceuticals (NASDAQ:FENC) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga